drugset / Trial / NCT02969356

Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)

NCT02969356 ↗

Phase 4 Completed 157 enrolled Ipsen
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this clinical study is to assess whether AbobotulinumtoxinA (Dysport®) injections in upper and lower limbs accompanied with a personal exercise plan called "Guided Self-rehabilitation Contract" (GSC) can improve voluntary movements in subjects with hemiparesis.

Timeline

Start
2016-12-18
Primary completion
2018-04-26
Completion
2018-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 1500 iu Intramuscular

Indications